Raised mammographic density: Causative mechanisms and biological consequences

Breast Cancer Research

Volumn 18, Issue 1, 2016, Pages

  Sherratt, Michael J ^a   McConnell, James C ^a   Streuli, Charles H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; RALOXIFENE; TAMOXIFEN; BIOLOGICAL MARKER;

ARTICLE; BODY MASS; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DENSITY; CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CONNECTIVE TISSUE; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; MAMMARY GLAND; MAMMOGRAPHY; MORPHOLOGY; NONHUMAN; OBESITY; RIGIDITY; RISK FACTOR; TUMOR MICROENVIRONMENT; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; GENETIC PREDISPOSITION; INCIDENCE; METABOLISM; PATHOLOGY; PROGNOSIS; RISK; STROMA CELL;

BIOMARKERS; BREAST DENSITY; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; PROGNOSIS; RISK; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 85008675591     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/S13058-016-0701-9     Document Type: Article

References (87)

1. Glukhova MA, Streuli CH. How integrins control breast biology. Curr Opin Cell Biol. 2013;25:633-41.
2. Muschler J, Streuli CH. Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol. 2010;2:a003202.
3. Streuli CH. Integrins and cell-fate determination. J Cell Sci. 2009;122:171-7.
4. Metcalfe AD, Hickman JA, Streuli CH. Programmed cell death and the mammary gland-the involvement of the Bcl-2 family members in the control of epithelial apoptosis. Biochem Soc Trans. 1996;24:347S.
5. Benusiglio PR et al. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study. Breast Cancer Res BCR. 2005;7:R204-9.
6. Types of breast cancer. http://www.cancerresearchuk.org/about-cancer/type/breast-cancer/about/types/.
7. Slamon DJ et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707-12.
8. Provenzano PP et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38.
9. Bredfeldt JS et al. Automated quantification of aligned collagen for human breast carcinoma prognosis. J Pathol Inform. 2014;5:28.
10. Boyd NF et al. Evidence that breast tissue stiffness is associated with risk of breast cancer. PLoS One. 2014;9:e100937.
11. Yaffe MJ. Mammographic density. Measurement of mammographic density. Breast Cancer Res. 2008;10(209).
12. Chen J-H, Gulsen G, Su M-Y. Imaging breast density: established and emerging modalities. Transl Oncol. 2015;8:435-45.
13. McConnell JC et al. Increased peri-ductal collagen micro-organization may contribute to raised mammographic density. Breast Cancer Res. 2016;18:5.
14. Highnam R, Brady M, Yaffe MJ, et al. Robust Breast Composition Measurement-Volpara (TM). In: Marti J, Oliver A, Freixenet J, et al, editors. Lecture Notes in Computer Science, vol. 6136. Girona, SPAIN: Conference: 10th International Workshop on Digital Mammography, Univ Girona, Comp Vision & Robot Grp. 2010. p. 342-9.
15. Ekpo EU, McEntee MF. Measurement of breast density with digital breast tomosynthesis-a systematic review. Br J Radiol. 2014;87:20140460.
16. Lubomir M, Hadjiiski GD. Medical Imaging 2015: Computer-Aided Diagnosis. Tourassi: Proc. of SPIE Vol. 9414, 941417. SPIE ˙ CCC code: 1605-7422/15/$18. 2015 doi:10.1117/12.2082691.
17. Yaghjyan L, Colditz GA, Rosner B, Tamimi RM. Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. Breast Cancer Res Treat. 2015;150:181-9.
18. Huo CW et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479-502.
19. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976;37:2486-92.
20. Pettersson A, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014;106. doi:10.1093/jnci/dju078.
21. Barker HE et al. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 2011;71:1561-72.
22. Levental KR et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891-906.
23. Warwick J et al. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res. 2014;16:451.
24. Harvey JA et al. Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause N Y N. 2008;15:67-73.
25. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003;5:R129-35.
26. Skandalis SS et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignantappearing microcalcifications in non-palpable breast carcinomas. BMC Cancer. 2011;11:314.
27. Guo YP et al. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomark Prev. 2001;10:243-8.
28. Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn. 2006;235:3222-9.
29. Britt K, Ingman W, Huo C, Chew G, Thompson E. The pathobiology of mammographic density. J Cancer Biol Res. 2014;2:1021.
30. DeFilippis RA et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2012;2:826-39.
31. Huo CW et al. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res. 2015;17:79.
32. Acerbi I et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integr Biol Quant Biosci Nano Macro. 2015;7:1120-34.
33. Kadler KE. The needle in the ECM haystack. Nat Rev Mol Cell Biol. 2014;15:769.
34. Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. eLife. 2014;3:e01308.
35. O'Brien JH, Vanderlinden LA, Schedin PJ, Hansen KC. Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res. 2012;11:4894-905.
36. Norris RA et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem. 2007;101:695-711.
37. Wang Z, Ouyang G. Periostin: a bridge between cancer stem cells and their metastatic niche. Cell Stem Cell. 2012;10:111-2.
38. Grässel S, Bauer RJ. Collagen XVI in health and disease. Matrix Biol J Int Soc Matrix Biol. 2013;32:64-73.
39. Ratzinger S, Grässel S, Dowejko A, Reichert TE, Bauer RJ. Induction of type XVI collagen expression facilitates proliferation of oral cancer cells. Matrix Biol. 2011;30(2):118-25. doi:10.1016/j.matbio.2011.01.001. Epub 2011 Jan 18. PMID:21251976.
40. Pankow JS et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997;89:549-56.
41. Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev. 2006;15(4):612-7.
42. Odefrey F et al. Common genetic variants associated with breast cancer and mammographic density measures that predict disease. Cancer Res. 2010;70:1449-58.
43. Stevens KN et al. Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet. 2012;21:3299-305.
44. Vachon CM et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2012;21:1156-66.
45. Lindström S et al. Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet. 2011;43:185-7.
46. Fernandez-Navarro P et al. Genome wide association study identifies a novel putative mammographic density locus at 1q12-q21. Int J Cancer J Int Cancer. 2015;136:2427-36.
47. Stone J et al. Novel associations between common breast cancer susceptibility variants and risk-predicting mammographic density measures. Cancer Res. 2015;75:2457-67.
48. Brand JS et al. Identification of two novel mammographic density loci at 6Q25.1. Breast Cancer Res. 2015;17:75.
49. Ramón Y, Cajal T, et al. Mammographic density and breast cancer in women from high risk families. Breast Cancer Res. 2015;17:93.
50. Sun X et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res. 2013;19:4972-82.
51. Wang Y et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature. 2014;512:155-60.
52. Pardo I et al. Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank. Breast Cancer Res. 2014;16:R26.
53. Förnvik D et al. No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression. Breast Cancer Res Treat. 2013;141:187-95.
54. Lorenzen J et al. MR elastography of the breast: preliminary clinical results. RöFo Fortschritte Auf Dem Geb Röntgenstrahlen Nukl. 2002;174:830-4.
55. Wojcinski S et al. Ultrasound real-time elastography can predict malignancy in BI-RADS®-US 3 lesions. BMC Cancer. 2013;13:159.
56. Akhtar R, Sherratt MJ, Cruickshank JK, Derby B. Characterizing the elastic properties of tissues. Mater Today Kidlington Engl. 2011;14:96-105.
57. Danielson KG et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997;136:729-43.
58. Ishiba T et al. Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion. Sci Rep. 2014;4:7069.
59. El-Domyati M et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11:398-405.
60. Naylor EC, Watson REB, Sherratt MJ. Molecular aspects of skin ageing. Maturitas. 2011;69:249-56.
61. Sherratt MJ. Tissue elasticity and the ageing elastic fibre. Age Dordr Neth. 2009;31:305-25.
62. Bailey AJ. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev. 2001;122:735-55.
63. Sharaf H et al. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231. Biochim Biophys Acta. 1852;2015:429-41.
64. Morgan MP, Cooke MM, McCarthy GM. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia. 2005;10:181-7.
65. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009;9:108-22.
66. Sawada Y et al. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell. 2006;127:1015-26.
67. Mouw JK et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med. 2014;20:360-7.
68. Provenzano PP, Eliceiri KW, Keely PJ. Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol. 2009;19:638-48.
69. Dupont S et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179-83.
70. Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94:1287-312.
71. Olson EN, Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol. 2010;11:353-65.
72. Weinl C et al. Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J Clin Invest. 2013;123:2193-206.
73. Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009;10:75-82.
74. Maya-Mendoza A, Bartek J, Jackson DA, Streuli C. Cellular microenvironment controls the nuclear architecture of breast epithelia through β1-integrin. Cell Cycle. 2016;15:345.
75. Hariri M et al. Experimental manipulation of radiographic density in mouse mammary gland. Breast Cancer Res. 2004;6:R540-5.
76. Chew GL et al. High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers. Breast Cancer Res Treat. 2012;135:177-87.
77. Cuzick J et al. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst. 2011;103:744-52.
78. Brisson J, Brisson B, Coté G, Maunsell E, Bérubé S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev. 2000; 9(9):911-5.
79. Chen J-H et al. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging. 2011;29:91-8.
80. Lasco A et al. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women. Menopause N Y N. 2006;13:787-92.
81. Lienart V et al. Effect of preventive hormonal therapy on breast density: a systematic qualitative review. ScientificWorldJournal. 2014;2014:942386.
82. Li J et al. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol. 2013;31:2249-56.
83. Conklin MW et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178:1221-32.
84. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000;9(2):151-60. PMID:10698475.
85. Greendale GA et al. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003;95:30-7.
86. Yan S et al. Let-7f inhibits glioma cell proliferation, migration, and invasion by targeting periostin. J Cell Biochem. 2015;116:1680-92.
87. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13:223.